Last updated on March 2019

A Study to Assess the Safety Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis


Brief description of study

This is a study to evaluate the long-term safety and tolerability of bimekizumab in adult subjects with moderate to severe chronic plaque psoriasis (PSO).

Clinical Study Identifier: NCT03598790

Find a site near you

Start Over

Ps0014 940

Beverly, MA United States
  Connect »

Ps0014 929

Portland, OR United States
  Connect »

Ps0014 914

San Antonio, TX United States
  Connect »

Ps0014 622

Matsumoto, Japan
  Connect »

Ps0014 928

Fort Myers, FL United States
  Connect »

Ps0014 901

Newington, NH United States
  Connect »

Ps0014 947

Buffalo, NY United States
  Connect »

Ps0014 624

Obihiro, Japan
  Connect »

Ps0014 603

Sapporo, Japan
  Connect »

Ps0014 954

Skokie, IL United States
  Connect »

Ps0014 601

Fukuoka, Japan
  Connect »

Ps0014 618

Shinjuku-Ku, Japan
  Connect »

Ps0014 944

New Orleans, LA United States
  Connect »

Ps0014 671

Hamilton, Canada
  Connect »

Ps0014 675

Markham, Canada
  Connect »

Ps0014 663

Mississauga, Canada
  Connect »

Ps0014 607

Chiyoda-Ku, Japan
  Connect »

Ps0014 627

Itabashi-Ku, Japan
  Connect »

Ps0014 604

Minato-Ku, Japan
  Connect »

Ps0014 625

Nankoku, Japan
  Connect »

Ps0014 967

Santa Monica, CA United States
  Connect »

Ps0014 962

Owensboro, KY United States
  Connect »

Ps0014 657

Waterloo, Canada
  Connect »

Ps0014 250

Szolnok, Hungary
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.